Home
>
Stock Market
>
>
Aurobindo Pharma Ltd

Aurobindo Pharma Ltd share price and stock overview

Aurobindo Pharma Ltd (NSE: AUROPHARMA, BSE: 524804) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE406A01037 and a face value of Rs 1. As of 27 October 2026, it trades at Rs (1,590.00) with a market capitalisation of Rs 91485.09 crore. Figures are live and subject to change.

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

1,590.00 18.30 (1.16%) upARrowC

As on: 27-Oct-2026 , 07:47 AM

Market Cap(₹Cr) 91485.09

Book Value(₹Cr) 394.8213477

BSE Code : 524804 NSE Symbol : AUROPHARMA EPS(TTM) : 45.29 ISIN Demat : INE406A01037 P/E(TTM) : 35.11 Face Value(₹) : 1 Div & Yield % : 0.25

Today Market

Stock Performance

Today Market

Today's High

73,606.75

Todday's Low

72,514.57

Open at

72,990.04

Previous Close

73,123.83

Volumes

Avg Price

482.92

Historical Performance

News

26 Oct 26

Aurobindo Pharma to review Q2 financial results and interim dividend at board meeting

Aurobindo Pharma Ltd. will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended September 30, 2026, and to decide on the payment of an interim dividend, if any, for the financial year 2026-27.

05 Oct 26

Aurobindo Pharma reported dematerialization details to Indian exchanges, per regulatory requirements

Aurobindo Pharma Limited, in a filing on October 5, 2026, certified that details of dematerialized and rematerialized securities for the quarter ended September 30, 2026, have been furnished to the National Stock Exchange of India Limited and BSE Limited, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, with confirming letters from KFin Technologies Limited dated October 1, 2026, enclosed for reference.

02 Oct 26

Aurobindo Pharma's A1 USA Inc. acquired A1 Biochem Labs LLC for $15.247 million

Aurobindo Pharma Limited announced that its wholly owned subsidiary, A1 USA Inc., has acquired 100% ownership of A1 Biochem Labs LLC for a cash consideration of USD 15.

01 Oct 26

Aurobindo Pharma subsidiary Apitoria Pharma grants Dr. Gadikota a 20% stake in A1 Biochem Labs

Aurobindo Pharma Limited disclosed that Apitoria Pharma Private Limited, its wholly owned subsidiary, has completed the allotment of securities to Dr.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
26-10-26	1562.40	1591.30	1553.00	1590.00	473129	43551	745577766.10	22753.20
23-10-26	1607.70	1608.80	1547.80	1571.70	650602	40505	1019367957.70	22600.00
22-10-26	1570.00	1610.90	1547.70	1610.90	1115532	51638	1772329396.70	22687.65
21-10-26	1621.40	1636.90	1564.00	1578.80	1219785	83318	1934545144.80	22811.35
19-10-26	1662.10	1681.60	1615.60	1621.40	736433	47670	1212366840.10	22888.95
16-10-26	1677.90	1681.70	1655.00	1666.90	796734	62540	1326489566.90	23146.15
15-10-26	1653.20	1684.30	1647.10	1677.90	762099	63576	1274654838.20	22997.35
14-10-26	1684.00	1687.70	1654.10	1662.90	899872	40462	1501011888.20	22622.70
13-10-26	1706.90	1706.90	1665.50	1684.60	953166	49269	1599124094.30	22721.95
12-10-26	1692.50	1715.00	1681.00	1706.90	1190866	44961	2023835273.60	22363.35

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

91485.09

PE Ratio

35.11

PB Ratio

4.03

Dividend Yield

0.25

ROE

11.17

ROCE

12.91

Book Value (₹)

394.8213477

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	17690341	3.07	17690341	1
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

17690341

3.07

17690341

Indian

Bodies Corporate-Indian (Promoter & Group)	210859525	36.65	210859525	4
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	69947860	12.16	69947860	9
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

280807385

48.80

280807385

Total ShareHolding for Promoter & Group

298497726

51.88

298497726

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	422602	0.07	422602	3
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	100169804	17.41	100169804	756
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	27842941	4.84	27842941	25
Mutual Funds / UTI	93868012	16.31	93868012	44
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	18398182	3.20	18398182	43
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

240701541

41.83

240701541

871

Non Institution

Bodies Corporate	3414985	0.59	3413875	1661
Clearing Members	23642	0.00	23642	7
Directors & their Relatives	4010	0.00	4010	2
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	2052698	0.36	2052698	7899
Foreign Non Institution Other	410	0.00	410	1
Hindu Undivided Families	832155	0.14	832155	3630
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	1878878	0.33	1878878	5
Individuals holding nominal share capital up to Rs. 1 lakh	27006390	4.69	26438340	219622
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	32255	0.01	32255	20
Others	928095	0.16	928095	4

Sub Total

36178628

6.29

35609468

232852

Total Public Shareholding

276880169

48.12

276311009

233723

Total of Promoter & Public ShareHolding

575377895

100.00

574808735

233737

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

575377895

100.00

574808735

233737

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	33,653.08	31,723.73	29,001.87	24,855.38	23,455.49
OPM (%)	15.38	15.97	15.76	10.51	14.92
OP	5,177.18	5,066.29	4,571.85	2,612.50	3,500.71
Other Income	492.09	621.85	557.38	290.59	320.35
PBIDT	7,274.01	7,172.95	6,191.36	3,997.56	4,547.90
INTEREST	383.97	457.24	289.71	140.48	48.64
PBDT	6,890.04	6,715.71	5,901.65	3,857.08	4,499.26
PBT	5,046.52	5,066.29	4,188.13	2,612.50	3,244.77
EO	-65.33	0.00	-191.86	0.00	-127.97
PBT after EO	5,111.85	5,066.29	4,379.99	2,612.50	3,372.74
TAXES	1,608.88	1,582.72	1,211.02	684.85	725.63
PAT	3,504.75	3,485.88	3,172.97	1,927.50	2,648.15
EPS	60.34	59.81	54.16	32.90	45.20
Raw Material	30.62	33.84	37.16	38.83	31.43
Power and Fuel	3.32	3.19	2.85	3.39	2.67
Employee Cost	15.42	14.11	13.53	14.17	14.71
Other Manufacturing Expenses	1.53	1.38	1.39	1.58	1.79
Selling and Administration Expenses	14.21	14.48	13.70	14.91	14.21
Miscellaneous Expenses	2.25	2.31	2.38	3.00	1.96
Revenue (Growth %)	6.08	9.39	16.68	5.97	-5.32
PBIDT (Growth %)	1.41	15.85	54.88	-12.10	-46.33
PAT (Growth %)	0.54	9.86	64.62	-27.21	-50.36
PBIDT (Margin %)	21.61	22.61	21.35	16.08	19.39
PAT (Margin %)	10.41	10.99	10.94	7.75	11.29

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	58.08	58.08	58.59	58.59	58.59	58.59
Reserves Total	22659.61	20476.03	19664.23	17975.44	17058.75	15866.02
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	22717.69	20534.11	19722.82	18034.03	17117.34	15924.61
Secured Loans	1905.50	1842.41	1431.99	1922.78	288.75	841.50
Unsecured Loans	2379.74	2804.19	1428.75	2280.38	1606.14	3186.02
Total Debt	4285.24	4646.60	2860.74	4203.16	1894.89	4027.52
Other Liabilities	73.17	53.30	46.00	87.31	5.03	0.00
Total Liabilities	27076.10	25234.01	22629.56	22324.50	19017.26	19952.13
APPLICATION OF FUNDS :
Gross Block	4633.15	4230.61	4043.49	6214.71	5724.90	6820.35
Less : Accumulated Depreciation	2089.42	1893.81	1624.36	2527.21	2139.07	2348.28
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2543.73	2336.80	2419.13	3687.50	3585.83	4472.07
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	228.55	87.53	132.68	239.09	225.15	734.89
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	17562.35	15209.57	13393.44	8105.37	6584.36	5009.93
Current Assets, Loans & Advances
Inventories	2360.57	2359.28	2367.60	4125.26	3356.18	4841.38
Sundry Debtors	4209.68	4195.05	3776.59	4560.26	3973.24	5928.01
Cash and Bank Balance	162.50	298.36	94.34	373.41	50.78	386.18
Loans and Advances	562.93	836.70	1000.59	906.05	2454.90	1093.25
Total Current Assets	7295.68	7689.39	7239.12	9964.98	9835.10	12248.82
Less : Current Liabilities and Provisions
Current Liabilities	2021.21	2092.61	2285.86	2396.31	2243.30	2553.47
Provisions	78.31	85.01	119.65	122.09	103.36	250.01
Total Current Liabilities & Provisions	2099.52	2177.62	2405.51	2518.40	2346.66	2803.48
Net Current Assets	5196.16	5511.77	4833.61	7446.58	7488.44	9445.34
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	41.01	51.87	47.45	55.24	43.82	68.61
Deferred Tax Liability	144.77	153.30	166.36	271.15	280.85	501.99
Net Deferred Tax	-103.76	-101.43	-118.91	-215.91	-237.03	-433.38
Other Assets	1649.07	2189.77	1969.61	3061.87	1370.51	723.28
Total Assets	27076.10	25234.01	22629.56	22324.50	19017.26	19952.13
Contingent Liabilities	460.34	220.81	206.15	534.26	152.93	887.66

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	-2,447.54	1,719.48	-1,837.03	616.31	-1,072.35
Investing Activities	-1,614.54	-3,229.65	-151.58	-2,050.16	-1,995.50
Net Cash Flow	-335.37	306.00	-273.81	211.94	-134.83
Operating Activities	3,726.71	1,816.17	1,714.80	1,645.79	2,933.02

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Pharmalabs...

823.10

(+0.27%)

Accent Microcell...

662.25

(+11.77%)

Accretion Pharma...

186.00

(+2.14%)

Achyut Healthcar...

Advanced Enzyme ...

252.15

(+1.53%)

Akums Drugs & Ph...

686.60

(+2.63%)

Albert David Ltd

777.10

(+1.75%)

Alembic Pharmace...

766.40

(+0.83%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

MRK

M R Kumar

Chairman & Independent Directo

Executive

KNR

Kambam Nityananda Reddy

Vice Chairman & M.D.

Executive

Functional Directors

MMM

M Madan Mohan Reddy

E D & Wholetime Director

Dir.

PVR

P V Ramprasad Reddy

Non Executive Director

Exec.

Independent Directors

PSC

Penaka Sarath Chandra Reddy

Non-Exec & Non-Independent Dir

Ind.

GPV

Girish Paman Vanvari

Independent Non Exe. Director

Ind.

Santanu Mukherjee

Independent Non Exe. Director

Ind.

Satakarni Makkapati

Non-Exec & Non-Independent Dir

Ind.

PKS

Punita Kumar Sinha

Independent Non Exe. Director

Ind.

Other Officials

BAR

B Adi Reddy

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Aurobindo Pharma Ltd? −

Aurobindo Pharma Ltd trades on NSE under AUROPHARMA and on BSE under code 524804. The ISIN is INE406A01037 and the face value is Rs 1.

What is the share price of Aurobindo Pharma Ltd today? +

As of 27 October 2026, Aurobindo Pharma Ltd trades at Rs 1,590.00, a change of 18.30 (1.16%) on the day. Prices are live and subject to change.

What is the market capitalisation of Aurobindo Pharma Ltd? +

As of 27 October 2026, Aurobindo Pharma Ltd has a market cap of about Rs 91485.09 crore. This figure is live and moves with the share price.

Is Aurobindo Pharma Ltd profitable? +

In March 2026, Aurobindo Pharma Ltd reported a profit after tax of Rs 3,504.75 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Aurobindo Pharma Ltd? +

: As of 27 October 2026, the PE (TTM) for Aurobindo Pharma Ltd is 35.11 and the price-to-book ratio is 4.03. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Aurobindo Pharma Ltd pay a dividend? +

As of 27 October 2026, the dividend yield for Aurobindo Pharma Ltd is 0.25%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Aurobindo Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 51.88% of Aurobindo Pharma Ltd. Public shareholding is 48.12%, including mutual funds at 16.31% and foreign institutional investors at 17.41%.

What were the latest annual financials of Aurobindo Pharma Ltd? +

In March 2026, Aurobindo Pharma Ltd reported net sales of Rs 33,653.08 crore, revenue growth of 6.08%, and earnings per share of Rs 60.34.